This finding also described the novel compounds for treating Alzheimer’s and SCA by inhibiting AChE, β-amyloid accumulation in the brain and degenerative changes in the cerebellum and spinal cord, respectively. The gene discussed is ACHE; the disease is autosomal dominant cerebellar ataxia.